ArticleMolecular therapy oncolytics2020

Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy.

Tomoko Fujiyuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.